Orion Portfolio Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,767
Closed -$234K – 1921
2024
Q4
$234K Sell
1,767
-44
-2% -$6.19K ﹤0.01% 1678
2024
Q3
$264K Sell
1,811
-105
-5% -$15.2K ﹤0.01% 1583
2024
Q2
$263K Buy
+1,916
New +$256K ﹤0.01% 1511
2023
Q2
– Sell
-1,774
Closed -$229K – 1647
2023
Q1
$229K Sell
1,774
-883
-33% -$116K ﹤0.01% 1452
2022
Q4
$349K Buy
2,657
+264
+11% +$34.1K 0.01% 619
2022
Q3
$280K Sell
2,393
-95
-4% -$11.8K 0.01% 599
2022
Q2
$293K Buy
+2,488
New +$295K 0.01% 560
2021
Q4
– Sell
-1,779
Closed -$288K – 712
2021
Q3
$288K Buy
+1,779
New +$299K 0.01% 532
2021
Q1
– Sell
-23,672
Closed -$3.59M – 554
2020
Q4
$3.59M Sell
23,672
-726
-3% -$104K 0.17% 91
2020
Q3
$3.3M Sell
24,398
-1,682
-6% -$228K 0.17% 87
2020
Q2
$3.56M Sell
26,080
-406
-2% -$51.8K 0.19% 78
2020
Q1
$2.85M Sell
26,486
-2,960
-10% -$341K 0.2% 71
2019
Q4
$3.55M Buy
+29,446
New +$3.29M 0.28% 64

Other funds holding IBB

Orion Portfolio Solutions's IBB Position: Q1 2025 in Review

Orion Portfolio Solutions sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 1,767 shares — an estimated $234K sold.

Orion Portfolio Solutions first reported a position in IBB in Q4 2019 and held it in 13 quarters. The position peaked at $3.59M in Q4 2020. 835 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Orion Portfolio Solutions reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Orion Portfolio Solutions sold 1,767 iShares Biotechnology ETF shares in Q1 2025, an estimated $234K.
  • Orion Portfolio Solutions first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 13 quarters.
  • Orion Portfolio Solutions's iShares Biotechnology ETF position peaked at $3.59M in Q4 2020.
  • 835 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.